[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Cyclospora Diagnostic Testing Market Growth (Status and Outlook) 2023-2029

March 2023 | 102 pages | ID: G38E405D0DA6EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Cyclospora cayetanensis, a single-celled coccidian parasitic pathogen, causes intestinal infection resulting in diarrhea. In medical terminology, this diarrheal infection is referred as cyclospora infection (cyclosporiasis).

LPI (LP Information)' newest research report, the “Cyclospora Diagnostic Testing Industry Forecast” looks at past sales and reviews total world Cyclospora Diagnostic Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cyclospora Diagnostic Testing sales for 2023 through 2029. With Cyclospora Diagnostic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cyclospora Diagnostic Testing industry.

This Insight Report provides a comprehensive analysis of the global Cyclospora Diagnostic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cyclospora Diagnostic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cyclospora Diagnostic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cyclospora Diagnostic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cyclospora Diagnostic Testing.

The global Cyclospora Diagnostic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Cyclospora Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Cyclospora Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Cyclospora Diagnostic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Cyclospora Diagnostic Testing players cover Thermo Fisher Scientific, Beckman Coulter, Inc, bioMerieux, Inc., CEPHEID, Diamedix Corporation, Hologic, Inc, Nanogen, Inc., Ortho Clinical Diagnostics (a Johnson & Johnson company) and DiaSorin S.p.A., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Cyclospora Diagnostic Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
  • Acid-fast Staining
  • Safranin Staining
Segmentation by application
  • Commercial or Private Laboratories
  • Hospitals
  • Public Health Labs
  • Physician Offices
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Thermo Fisher Scientific
  • Beckman Coulter, Inc
  • bioMerieux, Inc.
  • CEPHEID
  • Diamedix Corporation
  • Hologic, Inc
  • Nanogen, Inc.
  • Ortho Clinical Diagnostics (a Johnson & Johnson company)
  • DiaSorin S.p.A.
  • Roche Diagnostics (a division of Hoffmann-La Roche)
  • Siemens Healthcare
  • QIAGEN N.V.
  • Wako Chemicals USA, Inc.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Cyclospora Diagnostic Testing Market Size 2018-2029
  2.1.2 Cyclospora Diagnostic Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cyclospora Diagnostic Testing Segment by Type
  2.2.1 Acid-fast Staining
  2.2.2 Safranin Staining
2.3 Cyclospora Diagnostic Testing Market Size by Type
  2.3.1 Cyclospora Diagnostic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
2.4 Cyclospora Diagnostic Testing Segment by Application
  2.4.1 Commercial or Private Laboratories
  2.4.2 Hospitals
  2.4.3 Public Health Labs
  2.4.4 Physician Offices
2.5 Cyclospora Diagnostic Testing Market Size by Application
  2.5.1 Cyclospora Diagnostic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)

3 CYCLOSPORA DIAGNOSTIC TESTING MARKET SIZE BY PLAYER

3.1 Cyclospora Diagnostic Testing Market Size Market Share by Players
  3.1.1 Global Cyclospora Diagnostic Testing Revenue by Players (2018-2023)
  3.1.2 Global Cyclospora Diagnostic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cyclospora Diagnostic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CYCLOSPORA DIAGNOSTIC TESTING BY REGIONS

4.1 Cyclospora Diagnostic Testing Market Size by Regions (2018-2023)
4.2 Americas Cyclospora Diagnostic Testing Market Size Growth (2018-2023)
4.3 APAC Cyclospora Diagnostic Testing Market Size Growth (2018-2023)
4.4 Europe Cyclospora Diagnostic Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Cyclospora Diagnostic Testing Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Cyclospora Diagnostic Testing Market Size by Country (2018-2023)
5.2 Americas Cyclospora Diagnostic Testing Market Size by Type (2018-2023)
5.3 Americas Cyclospora Diagnostic Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Cyclospora Diagnostic Testing Market Size by Region (2018-2023)
6.2 APAC Cyclospora Diagnostic Testing Market Size by Type (2018-2023)
6.3 APAC Cyclospora Diagnostic Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Cyclospora Diagnostic Testing by Country (2018-2023)
7.2 Europe Cyclospora Diagnostic Testing Market Size by Type (2018-2023)
7.3 Europe Cyclospora Diagnostic Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Cyclospora Diagnostic Testing by Region (2018-2023)
8.2 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CYCLOSPORA DIAGNOSTIC TESTING MARKET FORECAST

10.1 Global Cyclospora Diagnostic Testing Forecast by Regions (2024-2029)
  10.1.1 Global Cyclospora Diagnostic Testing Forecast by Regions (2024-2029)
  10.1.2 Americas Cyclospora Diagnostic Testing Forecast
  10.1.3 APAC Cyclospora Diagnostic Testing Forecast
  10.1.4 Europe Cyclospora Diagnostic Testing Forecast
  10.1.5 Middle East & Africa Cyclospora Diagnostic Testing Forecast
10.2 Americas Cyclospora Diagnostic Testing Forecast by Country (2024-2029)
  10.2.1 United States Cyclospora Diagnostic Testing Market Forecast
  10.2.2 Canada Cyclospora Diagnostic Testing Market Forecast
  10.2.3 Mexico Cyclospora Diagnostic Testing Market Forecast
  10.2.4 Brazil Cyclospora Diagnostic Testing Market Forecast
10.3 APAC Cyclospora Diagnostic Testing Forecast by Region (2024-2029)
  10.3.1 China Cyclospora Diagnostic Testing Market Forecast
  10.3.2 Japan Cyclospora Diagnostic Testing Market Forecast
  10.3.3 Korea Cyclospora Diagnostic Testing Market Forecast
  10.3.4 Southeast Asia Cyclospora Diagnostic Testing Market Forecast
  10.3.5 India Cyclospora Diagnostic Testing Market Forecast
  10.3.6 Australia Cyclospora Diagnostic Testing Market Forecast
10.4 Europe Cyclospora Diagnostic Testing Forecast by Country (2024-2029)
  10.4.1 Germany Cyclospora Diagnostic Testing Market Forecast
  10.4.2 France Cyclospora Diagnostic Testing Market Forecast
  10.4.3 UK Cyclospora Diagnostic Testing Market Forecast
  10.4.4 Italy Cyclospora Diagnostic Testing Market Forecast
  10.4.5 Russia Cyclospora Diagnostic Testing Market Forecast
10.5 Middle East & Africa Cyclospora Diagnostic Testing Forecast by Region (2024-2029)
  10.5.1 Egypt Cyclospora Diagnostic Testing Market Forecast
  10.5.2 South Africa Cyclospora Diagnostic Testing Market Forecast
  10.5.3 Israel Cyclospora Diagnostic Testing Market Forecast
  10.5.4 Turkey Cyclospora Diagnostic Testing Market Forecast
  10.5.5 GCC Countries Cyclospora Diagnostic Testing Market Forecast
10.6 Global Cyclospora Diagnostic Testing Forecast by Type (2024-2029)
10.7 Global Cyclospora Diagnostic Testing Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Thermo Fisher Scientific
  11.1.1 Thermo Fisher Scientific Company Information
  11.1.2 Thermo Fisher Scientific Cyclospora Diagnostic Testing Product Offered
  11.1.3 Thermo Fisher Scientific Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Thermo Fisher Scientific Main Business Overview
  11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Beckman Coulter, Inc
  11.2.1 Beckman Coulter, Inc Company Information
  11.2.2 Beckman Coulter, Inc Cyclospora Diagnostic Testing Product Offered
  11.2.3 Beckman Coulter, Inc Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Beckman Coulter, Inc Main Business Overview
  11.2.5 Beckman Coulter, Inc Latest Developments
11.3 bioMerieux, Inc.
  11.3.1 bioMerieux, Inc. Company Information
  11.3.2 bioMerieux, Inc. Cyclospora Diagnostic Testing Product Offered
  11.3.3 bioMerieux, Inc. Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 bioMerieux, Inc. Main Business Overview
  11.3.5 bioMerieux, Inc. Latest Developments
11.4 CEPHEID
  11.4.1 CEPHEID Company Information
  11.4.2 CEPHEID Cyclospora Diagnostic Testing Product Offered
  11.4.3 CEPHEID Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 CEPHEID Main Business Overview
  11.4.5 CEPHEID Latest Developments
11.5 Diamedix Corporation
  11.5.1 Diamedix Corporation Company Information
  11.5.2 Diamedix Corporation Cyclospora Diagnostic Testing Product Offered
  11.5.3 Diamedix Corporation Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Diamedix Corporation Main Business Overview
  11.5.5 Diamedix Corporation Latest Developments
11.6 Hologic, Inc
  11.6.1 Hologic, Inc Company Information
  11.6.2 Hologic, Inc Cyclospora Diagnostic Testing Product Offered
  11.6.3 Hologic, Inc Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Hologic, Inc Main Business Overview
  11.6.5 Hologic, Inc Latest Developments
11.7 Nanogen, Inc.
  11.7.1 Nanogen, Inc. Company Information
  11.7.2 Nanogen, Inc. Cyclospora Diagnostic Testing Product Offered
  11.7.3 Nanogen, Inc. Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Nanogen, Inc. Main Business Overview
  11.7.5 Nanogen, Inc. Latest Developments
11.8 Ortho Clinical Diagnostics (a Johnson & Johnson company)
  11.8.1 Ortho Clinical Diagnostics (a Johnson & Johnson company) Company Information
  11.8.2 Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Product Offered
  11.8.3 Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Ortho Clinical Diagnostics (a Johnson & Johnson company) Main Business Overview
  11.8.5 Ortho Clinical Diagnostics (a Johnson & Johnson company) Latest Developments
11.9 DiaSorin S.p.A.
  11.9.1 DiaSorin S.p.A. Company Information
  11.9.2 DiaSorin S.p.A. Cyclospora Diagnostic Testing Product Offered
  11.9.3 DiaSorin S.p.A. Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 DiaSorin S.p.A. Main Business Overview
  11.9.5 DiaSorin S.p.A. Latest Developments
11.10 Roche Diagnostics (a division of Hoffmann-La Roche)
  11.10.1 Roche Diagnostics (a division of Hoffmann-La Roche) Company Information
  11.10.2 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product Offered
  11.10.3 Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Roche Diagnostics (a division of Hoffmann-La Roche) Main Business Overview
  11.10.5 Roche Diagnostics (a division of Hoffmann-La Roche) Latest Developments
11.11 Siemens Healthcare
  11.11.1 Siemens Healthcare Company Information
  11.11.2 Siemens Healthcare Cyclospora Diagnostic Testing Product Offered
  11.11.3 Siemens Healthcare Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.11.4 Siemens Healthcare Main Business Overview
  11.11.5 Siemens Healthcare Latest Developments
11.12 QIAGEN N.V.
  11.12.1 QIAGEN N.V. Company Information
  11.12.2 QIAGEN N.V. Cyclospora Diagnostic Testing Product Offered
  11.12.3 QIAGEN N.V. Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.12.4 QIAGEN N.V. Main Business Overview
  11.12.5 QIAGEN N.V. Latest Developments
11.13 Wako Chemicals USA, Inc.
  11.13.1 Wako Chemicals USA, Inc. Company Information
  11.13.2 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product Offered
  11.13.3 Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2023)
  11.13.4 Wako Chemicals USA, Inc. Main Business Overview
  11.13.5 Wako Chemicals USA, Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Cyclospora Diagnostic Testing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Acid-fast Staining
Table 3. Major Players of Safranin Staining
Table 4. Cyclospora Diagnostic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Cyclospora Diagnostic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Table 7. Cyclospora Diagnostic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Cyclospora Diagnostic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Table 10. Global Cyclospora Diagnostic Testing Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Cyclospora Diagnostic Testing Revenue Market Share by Player (2018-2023)
Table 12. Cyclospora Diagnostic Testing Key Players Head office and Products Offered
Table 13. Cyclospora Diagnostic Testing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Cyclospora Diagnostic Testing Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Cyclospora Diagnostic Testing Market Size Market Share by Regions (2018-2023)
Table 18. Global Cyclospora Diagnostic Testing Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Cyclospora Diagnostic Testing Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Cyclospora Diagnostic Testing Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Cyclospora Diagnostic Testing Market Size Market Share by Country (2018-2023)
Table 22. Americas Cyclospora Diagnostic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Table 24. Americas Cyclospora Diagnostic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Table 26. APAC Cyclospora Diagnostic Testing Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Cyclospora Diagnostic Testing Market Size Market Share by Region (2018-2023)
Table 28. APAC Cyclospora Diagnostic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Table 30. APAC Cyclospora Diagnostic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Table 32. Europe Cyclospora Diagnostic Testing Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Cyclospora Diagnostic Testing Market Size Market Share by Country (2018-2023)
Table 34. Europe Cyclospora Diagnostic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Table 36. Europe Cyclospora Diagnostic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Cyclospora Diagnostic Testing Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Cyclospora Diagnostic Testing
Table 45. Key Market Challenges & Risks of Cyclospora Diagnostic Testing
Table 46. Key Industry Trends of Cyclospora Diagnostic Testing
Table 47. Global Cyclospora Diagnostic Testing Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Cyclospora Diagnostic Testing Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Cyclospora Diagnostic Testing Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Cyclospora Diagnostic Testing Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Thermo Fisher Scientific Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 52. Thermo Fisher Scientific Cyclospora Diagnostic Testing Product Offered
Table 53. Thermo Fisher Scientific Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Thermo Fisher Scientific Main Business
Table 55. Thermo Fisher Scientific Latest Developments
Table 56. Beckman Coulter, Inc Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 57. Beckman Coulter, Inc Cyclospora Diagnostic Testing Product Offered
Table 58. Beckman Coulter, Inc Main Business
Table 59. Beckman Coulter, Inc Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Beckman Coulter, Inc Latest Developments
Table 61. bioMerieux, Inc. Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 62. bioMerieux, Inc. Cyclospora Diagnostic Testing Product Offered
Table 63. bioMerieux, Inc. Main Business
Table 64. bioMerieux, Inc. Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. bioMerieux, Inc. Latest Developments
Table 66. CEPHEID Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 67. CEPHEID Cyclospora Diagnostic Testing Product Offered
Table 68. CEPHEID Main Business
Table 69. CEPHEID Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. CEPHEID Latest Developments
Table 71. Diamedix Corporation Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 72. Diamedix Corporation Cyclospora Diagnostic Testing Product Offered
Table 73. Diamedix Corporation Main Business
Table 74. Diamedix Corporation Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Diamedix Corporation Latest Developments
Table 76. Hologic, Inc Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 77. Hologic, Inc Cyclospora Diagnostic Testing Product Offered
Table 78. Hologic, Inc Main Business
Table 79. Hologic, Inc Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Hologic, Inc Latest Developments
Table 81. Nanogen, Inc. Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 82. Nanogen, Inc. Cyclospora Diagnostic Testing Product Offered
Table 83. Nanogen, Inc. Main Business
Table 84. Nanogen, Inc. Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Nanogen, Inc. Latest Developments
Table 86. Ortho Clinical Diagnostics (a Johnson & Johnson company) Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 87. Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Product Offered
Table 88. Ortho Clinical Diagnostics (a Johnson & Johnson company) Main Business
Table 89. Ortho Clinical Diagnostics (a Johnson & Johnson company) Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Ortho Clinical Diagnostics (a Johnson & Johnson company) Latest Developments
Table 91. DiaSorin S.p.A. Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 92. DiaSorin S.p.A. Cyclospora Diagnostic Testing Product Offered
Table 93. DiaSorin S.p.A. Main Business
Table 94. DiaSorin S.p.A. Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. DiaSorin S.p.A. Latest Developments
Table 96. Roche Diagnostics (a division of Hoffmann-La Roche) Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 97. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Product Offered
Table 98. Roche Diagnostics (a division of Hoffmann-La Roche) Main Business
Table 99. Roche Diagnostics (a division of Hoffmann-La Roche) Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. Roche Diagnostics (a division of Hoffmann-La Roche) Latest Developments
Table 101. Siemens Healthcare Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 102. Siemens Healthcare Cyclospora Diagnostic Testing Product Offered
Table 103. Siemens Healthcare Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. Siemens Healthcare Main Business
Table 105. Siemens Healthcare Latest Developments
Table 106. QIAGEN N.V. Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 107. QIAGEN N.V. Cyclospora Diagnostic Testing Product Offered
Table 108. QIAGEN N.V. Main Business
Table 109. QIAGEN N.V. Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. QIAGEN N.V. Latest Developments
Table 111. Wako Chemicals USA, Inc. Details, Company Type, Cyclospora Diagnostic Testing Area Served and Its Competitors
Table 112. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Product Offered
Table 113. Wako Chemicals USA, Inc. Main Business
Table 114. Wako Chemicals USA, Inc. Cyclospora Diagnostic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Wako Chemicals USA, Inc. Latest Developments

LIST OF FIGURES

Figure 1. Cyclospora Diagnostic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cyclospora Diagnostic Testing Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cyclospora Diagnostic Testing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cyclospora Diagnostic Testing Sales Market Share by Country/Region (2022)
Figure 8. Cyclospora Diagnostic Testing Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cyclospora Diagnostic Testing Market Size Market Share by Type in 2022
Figure 10. Cyclospora Diagnostic Testing in Commercial or Private Laboratories
Figure 11. Global Cyclospora Diagnostic Testing Market: Commercial or Private Laboratories (2018-2023) & ($ Millions)
Figure 12. Cyclospora Diagnostic Testing in Hospitals
Figure 13. Global Cyclospora Diagnostic Testing Market: Hospitals (2018-2023) & ($ Millions)
Figure 14. Cyclospora Diagnostic Testing in Public Health Labs
Figure 15. Global Cyclospora Diagnostic Testing Market: Public Health Labs (2018-2023) & ($ Millions)
Figure 16. Cyclospora Diagnostic Testing in Physician Offices
Figure 17. Global Cyclospora Diagnostic Testing Market: Physician Offices (2018-2023) & ($ Millions)
Figure 18. Global Cyclospora Diagnostic Testing Market Size Market Share by Application in 2022
Figure 19. Global Cyclospora Diagnostic Testing Revenue Market Share by Player in 2022
Figure 20. Global Cyclospora Diagnostic Testing Market Size Market Share by Regions (2018-2023)
Figure 21. Americas Cyclospora Diagnostic Testing Market Size 2018-2023 ($ Millions)
Figure 22. APAC Cyclospora Diagnostic Testing Market Size 2018-2023 ($ Millions)
Figure 23. Europe Cyclospora Diagnostic Testing Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa Cyclospora Diagnostic Testing Market Size 2018-2023 ($ Millions)
Figure 25. Americas Cyclospora Diagnostic Testing Value Market Share by Country in 2022
Figure 26. United States Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC Cyclospora Diagnostic Testing Market Size Market Share by Region in 2022
Figure 31. APAC Cyclospora Diagnostic Testing Market Size Market Share by Type in 2022
Figure 32. APAC Cyclospora Diagnostic Testing Market Size Market Share by Application in 2022
Figure 33. China Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 37. India Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe Cyclospora Diagnostic Testing Market Size Market Share by Country in 2022
Figure 40. Europe Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Figure 41. Europe Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Figure 42. Germany Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 43. France Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa Cyclospora Diagnostic Testing Market Size Market Share by Application (2018-2023)
Figure 50. Egypt Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country Cyclospora Diagnostic Testing Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 56. APAC Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 57. Europe Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 59. United States Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 60. Canada Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 61. Mexico Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 62. Brazil Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 63. China Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 64. Japan Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 65. Korea Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 67. India Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 68. Australia Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 69. Germany Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 70. France Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 71. UK Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 72. Italy Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 73. Russia Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 74. Spain Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 75. Egypt Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 76. South Africa Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 77. Israel Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 78. Turkey Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries Cyclospora Diagnostic Testing Market Size 2024-2029 ($ Millions)
Figure 80. Global Cyclospora Diagnostic Testing Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global Cyclospora Diagnostic Testing Market Size Market Share Forecast by Application (2024-2029)


More Publications